FDA Updates HIV Drug Info to Include MI Danger

WASHINGTON (MedPage Today) The FDA has added increased risk of myocardial infarction and dyslipidemia to prescribing information for the HIV drug fosamprenavir calcium (Lexiva) in tablet and oral suspension.

source : www.medpagetoday.com

Related News:

• More Support for Compression-Only CPR (CME/CE, with video)
• Sleep Disorder May Signal Neuro Conditions to Come (CME/CE, with video)
• Hospital Expansion Not Key to PCI Access in STEMI (CME/CE, with audio)
• Racial Differences in CABG Socioeconomic, Too (CME/CE, with audio)
• Similar Results with Early, Delayed ACL Surgery (CME/CE, with video)
• Model May Aid Decisions After Failed IVF (CME/CE, with audio)
• Happy Hour Comes With Stroke Risk for Fragile Few (CME/CE, with video)
• Glucosamine Fails to Ease Aching Backs (CME/CE, with video)
• For BP More Control Means Less Benefit in T2D (CME/CE, with video)
• ADA: TZD Debate Rages, but What Does It Mean? (CME/CE, with video)

Details :
Submited at Friday, December 4th, 2009 at 1:00 pm on Cardiology by admin
Comment RSS 2.0 - leave a comment - trackback